Pregnant Women for Malaria Surveillance
MiPMon
Pregnant Women as a Sentinel Group for Malaria Surveillance in an Era of Changing Malaria Transmission
MiPMon
Pregnant Women as a Sentinel Group for Malaria Surveillance in an Era of Changing Malaria Transmission
Sponsor study identifier
NIH
observational
16,958
0 countries
N/A
Study Start
November 1, 2016
Actual (reported)Primary Completion
October 31, 2019
Actual (reported)Study Completion
October 31, 2019
Actual (reported)Close monitoring of malaria in pregnancy can help to quickly identify changes in malaria burden and related adverse outcomes, especially in areas embarking in malaria elimination activities. The easy access of pregnant women through antenatal clinics, combined with the potential of pregnancy-specific serology to assess cumulative exposure to malaria, can provide the basis for new sentinel surveillance methods. Such an approach has the potential to guide clinical practice and the choice of malaria control/preventive tools adapted to areas of different transmission intensity, as well as to generate sensitive metrics of transmission during malaria elimination activities.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 31, 2019
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 1, 2016
Actual (reported)October 31, 2019
Actual (reported)October 31, 2019
Actual (reported)May 28, 2020
Actual (reported)June 2, 2020
Actual (reported)Number of pregnant women with a P. falciparum infection
P. falciparum detected by qPCR
3 years
Number of pregnant women with maternal anemia
3 years
Number of pregnant women delivering a newborn with low birthweight
3 years
Pregnant women attending the Manhiça District Hospital
Pregnant women attending the Ilha Josina Health Center
Pregnant women attending the Magude Health Center
No intervention
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Pregnant women attending three health centers in areas of Maputo Province with different levels of malaria transmission (Manhiça District Hospital \[Manhiça District\], Ilha Josina Health Center \[Manhiça District\] and Magude Health Center \[Magude District\])
Dried blood spots Plasma and PBMCS from a random selection of study participants
16,958 participants (actual enrollment reported by the registry).
First Submitted
May 28, 2020
First Posted
June 2, 2020
Study Start
November 1, 2016
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
October 31, 2019
Actual (reported)Study Completion
October 31, 2019
Actual (reported)Last Updated
June 9, 2020
Record last verified: 2020-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: